NIH’s Dr. Carl Dieffenbach Shares Highlights from Thursday at AIDS 2014

Content From: Miguel Gomez, Director,, and Senior Communications Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human ServicesPublished: July 24, 20141 min read


At the conclusion of Thursday’s sessions at the 20th International AIDS Conference (AIDS 2014Exit Disclaimer) in Melbourne, Australia, we spoke again with Dr. Carl Dieffenbach from NIH/NIAID by Dr. Kenneth Mayer of Boston’s Fenway Health and Harvard Medical School. In addition to effectively deploying those tools, Dr. Mayer and others at the conference called for advancing research underway to develop new or better tools, including an HIV vaccine and vaginal ring to prevent HIV transmission. Additionally, researchers are studying novel means of delivering PrEP—such as injectables, implantables, and patches that would make PrEP easier to use and increase adherence. (Read more about vaccines and microbicides.)


Watch Dr. Dieffenbach’s remarks above. Check back tomorrow for Dr. Dieffenbach’s final conference observation from AIDS 2014.

About AIDS 2014

Gathered under the theme of “Stepping Up the Pace,” some 12,000 participants from 200 countries around the world have gathered in Melbourne for the 20th International AIDS Conference, known as AIDS 2014. This biennial gathering for those working in the field of HIV, including scientists, medical practitioners, activists, policymakers, people living with HIV and others committed to ending the epidemic. For more coverage from the conference visit AIDS 2014.